As the person below who was
As the person below who was present for the Charnwood closure (but no longer working for AZ) I can only say the following. AZ may seem ruthless regarding cuts and closures but then what is the...
View ArticleShould FDA Oversee IRS and Justice?
Imagine delegating approval authority for a critical quality system function and not writing it down or remembering when you did it. How long would it take the FDA to issue a 483 or WL for lack of...
View ArticleNorovirus and C diff killed in a minute !
Interestingly I found this company who have only just entered the UK market. I have bought their product and amazed at the validation their
View ArticleFeds offer more benefits to 390 laid-off Pfizer workers
Does anybody know details about this? Apparently some laid off workers from execupharm sued and received more unemployment benefits. Does this apply to other laid off workers?
View Article"Tossingly amazing. We make
"Tossingly amazing. We make much more money here and produce nothing (documented). Thank you for asking. Jim Merson" Oh James, you make me smile. Now that I am gone.
View ArticleWow - That comment was just
Wow - That comment was just outstanding! "Made in Taiwan" - really? The ignorance and sour grapes on this stream are just amazing. Funny thing is - Roche left Ventana alone for quite a while. The...
View Article'ME is toast' : What, all of
'ME is toast' : What, all of it ?! Its a fairly diverse dept so its difficult to see all of it being eliminated.
View ArticleME and MD merged. Two new
ME and MD merged. Two new functins "created", PR&D and PARD in all but name. Round and round and round and round and round.......
View ArticleSo if anyone was in any doubt
So if anyone was in any doubt up to this point of the monumental, directionless incompetence of the AstraZeneca leadership, they should be set straight by the end of play today..
View ArticleSangamo Biotech
In the lengthy and expensive U.S. regulatory approval process, just 16 per cent of drugs make it through to market. In the meantime, many biotech firms are keeping the lights on by issuing shares and...
View ArticleLMAO. PR&D and PARD back in
LMAO. PR&D and PARD back in all but name. At least that solves the issue about will ME move to Cambridge though..
View ArticleI don't think the problems
I don't think the problems are due to the "suits" or "skirts" per se, but they certainly haven't helped matters. The changes that have been made since their arrival have hindered not helped address the...
View ArticleThat's the price TMO agreed
That's the price TMO agreed to pay per share of issued LIFE stock to purchase the company. It doesn't necessarily mean that's the price LIFE stock will rise to, though it could.
View Article